Peter John Ratcliffe - 02 Jan 2024 Form 3 Insider Report for Immunocore Holdings plc (IMCR)

Role
Director
Signature
/s/ Peter J. Ratcliffe
Issuer symbol
IMCR
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
3
Filing time
02 Jan 2024, 16:55:35 UTC
Next filing
28 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMCR Ordinary Shares 333 02 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMCR Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 14,176 $25.83 Direct F1
holding IMCR Share Option (Right to Buy) 02 Jan 2024 Ordinary Shares 8,676 $58.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately exercisable.
F2 100% of the shares subject to the option award shall vest on May 16, 2024, subject to the Reporting Person's continuous service through such vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney